Barrington Research Reiterates Outperform on Dentsply Sirona, Maintains $51 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky has reiterated an 'Outperform' rating on Dentsply Sirona (NASDAQ:XRAY) and maintained a price target of $51.
August 04, 2023 | 5:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barrington Research has reiterated an 'Outperform' rating on Dentsply Sirona and maintained a price target of $51.
The reiteration of an 'Outperform' rating by Barrington Research indicates a positive outlook for Dentsply Sirona. The maintained price target of $51 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100